Polyclonal T-cell activation protocol stimulates preferential expansion of EBV-specific T-cell clones in vitro

By Hedfors Ida   Brinchmann Jan  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 5, 2004-05 ,pp. : 439-444

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced antitumor effect of combining chemotherapy with Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes in mice with EBV-related non-Hodgkin's lymphoma

By                                

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1233-1238

Science Publishers

Access to resources Recommend Favorite

Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma

By Allen Chan K.C.   Dennis Lo Y.M.  

Seminars in Cancer Biology, Vol. 12, Iss. 6, 2002-12 ,pp. : 489-496

Academic Press

Access to resources Recommend Favorite

EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells

By                        

International Journal of Oncology, Vol. 43, Iss. 5, 2013-01 ,pp. : 1541-1548

Spandidos Publications

Access to resources Recommend Favorite

Immunotherapy of renal cell carcinoma

By Gouttefangeas Cécile   Stenzl Arnulf   Stevanović Stefan   Rammensee Hans-Georg  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 1, 2007-01 ,pp. : 117-128

Springer Publishing Company

Access to resources Recommend Favorite